Dr. Robert Whitfield tested 694 surgical implant samples and found 29% contaminated with toxins like atrazine and organophosphates. He argues most clinics ignore patients' toxic burden before surgery, and introduces the SHARP method—assessing genetics, toxicity, gut health, food sensitivities, and hormonal balance—to improve outcomes.
This is all published material in the Journal of the American Medical Association. And in our patients, we have testing over and over again that reveals data like atrazine, like organophosphate. Published the largest PCR-tested explant capsule series in the world, shows 29% contamination rate in 694 consecutive samples. You know, we're constantly looking at and evaluating heavy metals and mycotoxins. Don't think there are many clinics like ours measuring toxic burden in the entire world. We think it's very important before surgery, and I hang my hat on it after surgery as well. I see what's been affecting patients to give me clues about why they may have other issues that develop chronically or that they just have to work through over time. So I think it's important to really ask the patients about their travel history, where they grew up, where they lived, what's been their exposures. The SHARP method for me, uh, helped fill in those gaps, looking at genetics, looking at toxicity burden, gut health, food sensitivities, hormonal balance. All those things that were outside of the standard purview. But in reality, it's a very, very, very efficient tool to help your patients, combined with our supplementation protocol, sleep hygiene, optimization of nutrition. All of that's put in place to really help patients, you know, have the most success.
